Literature DB >> 24009257

Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes.

Sami Oikarinen1, Sisko Tauriainen, Didier Hober, Bernadette Lucas, Andriani Vazeou, Amirbabak Sioofy-Khojine, Evangelos Bozas, Peter Muir, Hanna Honkanen, Jorma Ilonen, Mikael Knip, Päivi Keskinen, Marja-Terttu Saha, Heini Huhtala, Glyn Stanway, Christos Bartsocas, Johnny Ludvigsson, Keith Taylor, Heikki Hyöty.   

Abstract

Enteroviruses (EVs) have been connected to type 1 diabetes in various studies. The current study evaluates the association between specific EV subtypes and type 1 diabetes by measuring type-specific antibodies against the group B coxsackieviruses (CVBs), which have been linked to diabetes in previous surveys. Altogether, 249 children with newly diagnosed type 1 diabetes and 249 control children matched according to sampling time, sex, age, and country were recruited in Finland, Sweden, England, France, and Greece between 2001 and 2005 (mean age 9 years; 55% male). Antibodies against CVB1 were more frequent among diabetic children than among control children (odds ratio 1.7 [95% CI 1.0-2.9]), whereas other CVB types did not differ between the groups. CVB1-associated risk was not related to HLA genotype, age, or sex. Finnish children had a lower frequency of CVB antibodies than children in other countries. The results support previous studies that suggested an association between CVBs and type 1 diabetes, highlighting the possible role of CVB1 as a diabetogenic virus type.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24009257     DOI: 10.2337/db13-0620

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  62 in total

1.  Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.

Authors:  Amir-Babak Sioofy-Khojine; Jussi Lehtonen; Noora Nurminen; Olli H Laitinen; Sami Oikarinen; Heini Huhtala; Outi Pakkanen; Tanja Ruokoranta; Minna M Hankaniemi; Jorma Toppari; Mari Vähä-Mäkilä; Jorma Ilonen; Riitta Veijola; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2018-02-05       Impact factor: 10.122

Review 2.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

Review 3.  Virus infections as potential targets of preventive treatments for type 1 diabetes.

Authors:  Noora Nurminen; Sami Oikarinen; Heikki Hyöty
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.

Authors:  Hanna Honkanen; Sami Oikarinen; Noora Nurminen; Olli H Laitinen; Heini Huhtala; Jussi Lehtonen; Tanja Ruokoranta; Minna M Hankaniemi; Valérie Lecouturier; Jeffrey W Almond; Sisko Tauriainen; Olli Simell; Jorma Ilonen; Riitta Veijola; Hanna Viskari; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2017-01-09       Impact factor: 10.122

5.  Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study.

Authors:  Ondrej Cinek; Lars C Stene; Lenka Kramna; German Tapia; Sami Oikarinen; Elisabet Witsø; Trond Rasmussen; Peter A Torjesen; Heikki Hyöty; Kjersti S Rønningen
Journal:  Diabetologia       Date:  2014-07-23       Impact factor: 10.122

Review 6.  The intestinal microbiome in type 1 diabetes.

Authors:  J L Dunne; E W Triplett; D Gevers; R Xavier; R Insel; J Danska; M A Atkinson
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  Antiviral antibody profiling by high-density protein arrays.

Authors:  Xiaofang Bian; Peter Wiktor; Peter Kahn; Al Brunner; Amritpal Khela; Kailash Karthikeyan; Kristi Barker; Xiaobo Yu; Mitch Magee; Clive H Wasserfall; David Gibson; Madeleine E Rooney; Ji Qiu; Joshua LaBaer
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

Review 8.  Type 1 diabetes-early life origins and changing epidemiology.

Authors:  Jill M Norris; Randi K Johnson; Lars C Stene
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-27       Impact factor: 32.069

Review 9.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 10.  Novel diagnostic and therapeutic approaches for autoimmune diabetes--a prime time to treat insulitis as a disease.

Authors:  Juha Grönholm; Michael J Lenardo
Journal:  Clin Immunol       Date:  2014-12-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.